Mary Kay Ladone
DirectoratBioventus· In proxies 2024–2025
Mary Kay Ladone sits on 3 public boards.
Boards1
- BioventusDirector · 4 yr on the boardIndependentAudit and Risk, Compensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- BioventusPublic company · 2 yr
- Director2024 – Present · 2 yrStock in role +177%
- Novanta Inc.Public company · 2 yr
- Director2024 – Present · 2 yrNo stock prices for these years
- Kestra Medical Technologies, Inc.Public company · 4 yr
- Director2022 – Present · 4 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?